Ursodeoxycholic acid for the prevention of colorectal adenomas and carcinomas

The primary objectives are to assess the effect of UDCA on the incidence or recurrence of sporadic CRAs and on the incidence of CRC compared to placebo. Secondary objectives are to identify the incidence of adverse effects resulted from the intervention.

This is a protocol.